Your browser doesn't support javascript.
loading
Dietary practices in methylmalonic acidaemia: a European survey.
Pinto, Alex; Evans, Sharon; Daly, Anne; Almeida, Manuela Ferreira; Assoun, Murielle; Belanger-Quintana, Amaya; Bernabei, Silvia Maria; Bollhalder, Sandra; Cassiman, David; Champion, Helena; Chan, Heidi; Corthouts, Karen; Dalmau, Jaime; Boer, Foekje de; Laet, Corinne De; Meyer, An de; Desloovere, An; Dianin, Alice; Dixon, Marjorie; Dokoupil, Katharina; Dubois, Sandrine; Eyskens, Francois; Faria, Ana; Fasan, Ilaria; Favre, Elisabeth; Feillet, François; Fekete, Anna; Gallo, Giorgia; Gingell, Cerys; Gribben, Joanna; Hansen, Kit Kaalund; Horst, Nienke Ter; Jankowski, Camille; Janssen-Regelink, Renske; Jones, Ilana; Jouault, Catherine; Kahrs, Gudrun Elise; Kok, Irene; Kowalik, Agnieszka; Laguerre, Catherine; Verge, Sandrine Le; Liguori, Alessandra; Lilje, Rina; Maddalon, Cornelia; Mayr, Doris; Meyer, Uta; Micciche, Avril; Och, Ulrike; Robert, Martine; Rocha, Júlio César.
Afiliação
  • Pinto A; Dietetic Department, Birmingham Women's and Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK.
  • Evans S; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Daly A; Birmingham Women's and Children's Hospital, Birmingham, UK.
  • Almeida MF; Centro de Genética Médica, Centro Hospitalar Universitário do Porto - CHUP, Porto, Portugal.
  • Assoun M; Unit for Multidisciplinary Research in Biomedicine, Abel Salazar Institute of Biomedical Sciences, University of Porto - UMIB/ICBAS/UP, Porto, Portugal.
  • Belanger-Quintana A; Centro de Referência na área de Doenças Hereditárias do Metabolismo, Centro Hospitalar Universitário do Porto - CHUP, Porto, Portugal.
  • Bernabei SM; Centre de référence des maladies héréditaires du métabolisme, Hôpital Necker Enfants Malades, Paris, France.
  • Bollhalder S; Unidad de Enfermedades Metabolicas, Servicio de Pediatria, Hospital Ramon y Cajal, Madrid, Spain.
  • Cassiman D; Children Hospital Bambino Gesù, Division of Artificial Nutrition, Rome, Italy.
  • Champion H; Univerisity Hospital Zurich, Zurich, Switzerland.
  • Chan H; Metabolic Center, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
  • Corthouts K; Addenbrooke's Hospital, Cambridge, UK.
  • Dalmau J; Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Boer F; Metabolic Center, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
  • Laet C; Unit of Nutrition and Metabolopathies, Hospital La Fe, Valencia, Spain.
  • Meyer A; University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Desloovere A; Hôpital Universitaire des Enfants, Reine Fabiola, Bruxelles, Belgium.
  • Dianin A; Center of Metabolic Diseases, University Hospital, Antwerp, Belgium.
  • Dixon M; University Hospital Ghent, Ghent, Belgium.
  • Dokoupil K; Department of Pediatrics, Regional Centre for Newborn Screening, Diagnosis and Treatment of Inherited Metabolic Diseases and Congenital Endocrine Diseases, University Hospital of Verona, Verona, Italy.
  • Dubois S; Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
  • Eyskens F; Dr. von Hauner Children's Hospital, Munich, Germany.
  • Faria A; Centre de référence des maladies héréditaires du métabolisme, Hôpital Necker Enfants Malades, Paris, France.
  • Fasan I; Center of Metabolic Diseases, University Hospital, Antwerp, Belgium.
  • Favre E; Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, EPE, Coimbra, Portugal.
  • Feillet F; Division of Inherited Metabolic Diseases, Department of Pediatrics, University Hospital of Padova, Padua, Italy.
  • Fekete A; Reference Center for Inborn Errors of Metabolism, Department of Pediatrics, Children's University Hospital, Nancy, France.
  • Gallo G; Reference Center for Inborn Errors of Metabolism, Department of Pediatrics, Children's University Hospital, Nancy, France.
  • Gingell C; Metabolic Centre of Vienna, Vienna, Austria.
  • Gribben J; Children Hospital Bambino Gesù, Division of Artificial Nutrition, Rome, Italy.
  • Hansen KK; Nottingham University Hospitals, Nottingham, UK.
  • Horst NT; Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Jankowski C; Charles Dent Metabolic Unit National Hospital for Neurology and Surgery, London, UK.
  • Janssen-Regelink R; Emma Children's Hospital, AMC Amsterdam, Amsterdam, The Netherlands.
  • Jones I; Bristol Royal Hospital for Children, University Hospitals Bristol NHS Foundation Trust, Bristol, UK.
  • Jouault C; Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kahrs GE; Center of Metabolic Diseases, University Hospital, Antwerp, Belgium.
  • Kok I; CHU Angers, Angers, France.
  • Kowalik A; Haukeland University Hospital, Bergen, Norway.
  • Laguerre C; Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
  • Verge SL; Institute of Mother and Child, Warsaw, Poland.
  • Liguori A; Centre de Compétence de L'Hôpital des Enfants de Toulouse, Toulouse, France.
  • Lilje R; Centre de référence des maladies héréditaires du métabolisme, Hôpital Necker Enfants Malades, Paris, France.
  • Maddalon C; Children Hospital Bambino Gesù, Division of Artificial Nutrition, Rome, Italy.
  • Mayr D; Oslo University Hospital, Oslo, Norway.
  • Meyer U; University Children's Hospital Zurich, Zurich, Switzerland.
  • Micciche A; Ernährungsmedizinische Beratung, Universitätsklinik für Kinder- und Jugendheilkunde, Salzburg, Austria.
  • Och U; Clinic of Paediatric Kidney, Liver and Metabolic Diseases, Medical School Hannover, Hannover, Germany.
  • Robert M; Evelina London Children's Hospital, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Rocha JC; University Children's Hospital, Munster, Germany.
J Pediatr Endocrinol Metab ; 33(1): 147-155, 2020 Jan 28.
Article em En | MEDLINE | ID: mdl-31846426
Background The dietary management of methylmalonic acidaemia (MMA) is a low-protein diet providing sufficient energy to avoid catabolism and to limit production of methylmalonic acid. The goal is to achieve normal growth, good nutritional status and the maintenance of metabolic stability. Aim To describe the dietary management of patients with MMA across Europe. Methods A cross-sectional questionnaire was sent to European colleagues managing inherited metabolic disorders (IMDs) (n=53) with 27 questions about the nutritional management of organic acidaemias. Data were analysed by different age ranges (0-6 months; 7-12 months; 1-10 years; 11-16 years; >16 years). Results Questionnaires were returned from 53 centres. Twenty-five centres cared for 80 patients with MMA vitamin B12 responsive (MMAB12r) and 43 centres managed 215 patients with MMA vitamin B12 non-responsive (MMAB12nr). For MMAB12r patients, 44% of centres (n=11/25) prescribed natural protein below the World Health Organization/Food and Agriculture Organization/United Nations University (WHO/FAO/UNU) 2007 safe levels of protein intake in at least one age range. Precursor-free amino acids (PFAA) were prescribed by 40% of centres (10/25) caring for 36% (29/80) of all the patients. For MMAB12nr patients, 72% of centres (n=31/43) prescribed natural protein below the safe levels of protein intake (WHO/FAO/UNU 2007) in at least one age range. PFAA were prescribed by 77% of centres (n=33/43) managing 81% (n=174/215) of patients. In MMAB12nr patients, 90 (42%) required tube feeding: 25 via a nasogastric tube and 65 via a gastrostomy. Conclusions A high percentage of centres used PFAA in MMA patients together with a protein prescription that provided less than the safe levels of natural protein intake. However, there was inconsistent practices across Europe. Long-term efficacy studies are needed to study patient outcome when using PFAA with different severities of natural protein restrictions in patients with MMA to guide future practice.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Alimentares / Inquéritos e Questionários / Erros Inatos do Metabolismo dos Aminoácidos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Região como assunto: Europa Idioma: En Revista: J Pediatr Endocrinol Metab Assunto da revista: ENDOCRINOLOGIA / PEDIATRIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Alimentares / Inquéritos e Questionários / Erros Inatos do Metabolismo dos Aminoácidos Tipo de estudo: Clinical_trials / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male / Newborn País/Região como assunto: Europa Idioma: En Revista: J Pediatr Endocrinol Metab Assunto da revista: ENDOCRINOLOGIA / PEDIATRIA Ano de publicação: 2020 Tipo de documento: Article País de publicação: Alemanha